Cite
HARVARD Citation
Lai, Z. et al. (2018). Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. Lancet. 391 (10126), pp. 1186-1196. [Online].